To explore the potential mechanisms by which STAT3-blocked HCC vaccine displayed its anti-tumor activity, BALB/c mice were immunized with the HCC vaccine three times, and then the major anti-tumor effector cells of these mice were analyzed 1 week after the last immunization. This evidence concerns the gene STAT3 and neoplasm.